Acadian Asset Management’s IGM Biosciences IGMS Stock Holding History

Acadian Asset Management’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-45,253	Closed	-$50K	–	1907
2025 Q2	$50K	Sell	45,253 -40,554	-47%	-$49.5K	﹤0.01%	1483
2025 Q1	$97K	Buy	+85,807	New	+$160K	﹤0.01%	1356
2024 Q1	–	Sell	-8,367	Closed	-$69K	–	1666
2023 Q4	$69K	Buy	+8,367	New	+$48.6K	﹤0.01%	1415

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Acadian Asset Management's IGMS Position: Q3 2025 in Review

Acadian Asset Management sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 45,253 shares — an estimated $50K sold.

Acadian Asset Management first reported a position in IGMS in Q4 2023 and held it in 3 quarters. The position peaked at $97K in Q1 2025. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

Acadian Asset Management reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
Acadian Asset Management sold 45,253 IGM Biosciences shares in Q3 2025, an estimated $50K.
Acadian Asset Management first reported a position in IGM Biosciences in Q4 2023 and held it in 3 quarters.
Acadian Asset Management's IGM Biosciences position peaked at $97K in Q1 2025.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on Acadian Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.